Medicenna Therapeutics Corp. Income Tax Expense Continuing Operations
Medicenna Therapeutics Corp. (MDNAF) reported Income Tax Expense Continuing Operations of CAD 0 for the 12-month period ending 2023-03-31, per its 20-F filed 2023-06-27.
Discontinued › Expense Statement › Income Tax
ifrs-full:IncomeTaxExpenseContinuingOperations · last filed 2023-06-27
| Period end | Income Tax Expense Continuing Operations 12 month |
|---|---|
| 2023-03-31 | 0.00 CAD 20-F · filed 2023-06-27 |
| 2022-03-31 | 0.00 CAD 20-F · filed 2023-06-27 |
| 2021-03-31 | 0.00 CAD 20-F · filed 2023-06-27 |
| 2020-03-31 | 0.00 CAD 20-F · filed 2022-06-22 |